ESMO welcomes the EU Council Recommendation on Vaccine-Preventable Cancers

ESMO – European Society for Medical Oncology shared a post on LinkedIn:

“ESMO welcomes today’s adoption of the EU Council Recommendation on Vaccine-Preventable Cancers, which aligns with calls made by the Society to tackle mis- and disinformation on Human Papilloma Viruses (HPV) and Hepatitis B Virus (HBV) vaccination.

To address declining vaccination rates that could overwhelm healthcare systems with cancers that can be prevented, and achieve the goals of Europe’s Beating Cancer Plan, we urge EU decision-makers to:

• Adopt a target of vaccinating 90% of girls and boys against HPV by 2030;
• Enable best-practice sharing on HPV/HBV vaccination with low- and middle-income countries;
• Ensure HPV/HBV vaccination introduction and expansion programs optimize national cancer screening;
• Secure at least 1 billion euro EU budget to support implementing the recommendations at national level.

ESMO fully supports driving back HPV/HBV-caused cancers and stands ready to engage with EU and national legislators in developing robust policies.”

Further information.
Source: ESMO/LinkedIn

The European Society for Medical Oncology (ESMO) represents over 35,000 oncology professionals across 172 countries and is a key resource for oncology education and information. ESMO’s primary mission is to enhance the quality of cancer care, spanning prevention, diagnosis, palliative care, and patient follow-up. It focuses on educating doctors, cancer patients, and the general public about best practices and the latest advancements in oncology, and advocates for equal access to optimal cancer care for all patients.